SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-117951
Filing Date
2024-04-26
Accepted
2024-04-26 16:02:50
Documents
23
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d431114ddef14a.htm   iXBRL DEF 14A 1078748
6 GRAPHIC g431114agio_page1.jpg GRAPHIC 241178
7 GRAPHIC g431114agio_page2.jpg GRAPHIC 137781
8 GRAPHIC g431114g01a42.jpg GRAPHIC 158443
9 GRAPHIC g431114g01b02.jpg GRAPHIC 54678
10 GRAPHIC g431114g18r02.jpg GRAPHIC 63997
11 GRAPHIC g431114g26x39.jpg GRAPHIC 69254
12 GRAPHIC g431114g33s20.jpg GRAPHIC 68756
13 GRAPHIC g431114g37h93.jpg GRAPHIC 77934
14 GRAPHIC g431114g65o58.jpg GRAPHIC 138312
  Complete submission text file 0001193125-24-117951.txt   4297031

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agio-20231231.xsd EX-101.SCH 5649
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20231231_def.xml EX-101.DEF 6194
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20231231_lab.xml EX-101.LAB 8648
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20231231_pre.xml EX-101.PRE 5397
26 EXTRACTED XBRL INSTANCE DOCUMENT d431114ddef14a_htm.xml XML 134228
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36014 | Film No.: 24883432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)